Logo image of CRGX

CARGO THERAPEUTICS INC (CRGX) Stock Analyst Earnings Estimates

NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD

4.49  +0.01 (+0.22%)

After market: 4.49 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CRGX revenue by date.CRGX revenue by date.
N/AN/AN/AN/AN/A
57.81%		N/A
164.91%		N/A
25.45%		N/A
14.12%
EBITDA
YoY % growth
CRGX ebitda by date.CRGX ebitda by date.
-5.96M-34.37M
-476.68%		-93.018M
-170.64%		-180.296M
-93.83%		N/A
21.93%		N/A
-2.17%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CRGX ebit by date.CRGX ebit by date.
-5.98M-34.77M
-481.44%		-96.71M
-178.14%		-187.37M
-93.74%		N/A
24.08%		N/A
13.99%		N/A
0.48%		N/A
27.56%		N/A
49.17%		N/A
592.61%		N/A
30.79%		N/A
14.76%
Operating Margin
CRGX operating margin by date.CRGX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CRGX eps by date.CRGX eps by date.
N/AN/AN/A-3.72
83.77%		N/A
23.02%		N/A
15.67%		N/A
-6.16%		N/A
-31.30%		N/A
26.06%		N/A
145.90%		N/A
108.04%		N/A
15.88%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth		-0.63
38.25%		-0.61
30.45%		-0.63
33.70%		-0.38
52.23%		-0.34
46.56%		-0.39
36.67%		-0.37
41.70%		-0.39
-2.70%		-0.32
6.06%		-0.38
2.63%
Revenue
Q2Q % growth		N/AN/AN/A
EBITDA
Q2Q % growth		-35.7M
25.86%		-32.64M
21.16%		-30.6M
28.94%		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-30.469M
38.22%		-28.935M
38.58%		-34.986M
30.22%		-19.074M
54.74%		-20.094M
34.05%		-21.624M
25.27%		-23.256M
33.53%		N/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 -0.79
9.20%		-0.74-0.05-6.83%
Q4 2024
Q2Q % growth		 -0.95
36.24%		-0.980.033.09%
Q3 2024
Q2Q % growth		 -0.88
98.14%		-1.150.2723.75%
Q2 2024
Q2Q % growth		 -1.02 -1.050.032.64%
Q1 2024
Q2Q % growth		 -0.87 -1.070.2019.02%
Q4 2023
Q2Q % growth		 -1.49 -1.47-0.02-1.21%
Q3 2023
Q2Q % growth		 -47.37 -2.84-44.53-1,568.55%
CRGX Yearly EPS VS EstimatesCRGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5 -10 -15 -20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
CRGX Yearly Revenue VS EstimatesCRGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 7.84% 0% -3.69%
RevenueN/A N/A N/A N/A